Collection and motif-based prediction of phosphorylation sites in human viruses

Science Signaling

Volumn 3, Issue 137, 2010, Pages

  Schwartz, Daniel ^a,b   Church, George M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOTRANSFERASE; SERINE; THREONINE; TYROSINE; VIRUS PROTEIN;

ARTICLE; DATA BASE; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; VALIDATION PROCESS; VIRUS REPLICATION;

AMINO ACID MOTIFS; DATABASES, PROTEIN; HUMANS; SEQUENCE ANALYSIS, PROTEIN; VIRAL PROTEINS; VIRUSES;

ANIMALIA;

EID: 77956620738     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2001099     Document Type: Article

References (74)

1. R. Zell, A. Krumbholz, P. Wutzler, Impact of global warming on viral diseases: What is the evidence? Curr. Opin. Biotechnol. 19, 652-660 (2008).
2. V. Neduva, R. B. Russell, Peptides mediating interaction networks: New leads at last. Curr. Opin. Biotechnol. 17, 465-471 (2006).
3. M. L. Miller, L. J. Jensen, F. Diella, C. Jørgensen, M. Tinti, L. Li, M. Hsiung, S. A. Parker, J. Bordeaux, T. Sicheritz-Ponten, M. Olhovsky, A. Pasculescu, J. Alexander, S. Knapp, N. Blom, P. Bork, S. Li, G. Cesareni, T. Pawson, B. E. Turk, M. B. Yaffe, S. Brunak, R. Linding, Linear motif atlas for phosphorylation-dependent signaling. Sci. Signal. 1, ra2 (2008).
4. P. Cohen, The role of protein phosphorylation in human health and disease. The Sir Hans Krebs Medal Lecture. Eur. J. Biochem. 268, 5001-5010 (2001).
5. T. S. Prasad, K. Kandasamy, A. Pandey, Human Protein Reference Database and Human Proteinpedia as discovery tools for systems biology. Methods Mol. Biol. 577, 67-79 (2009).
6. P. V. Hornbeck, I. Chabra, J. M. Kornhauser, E. Skrzypek, B. Zhang, PhosphoSite: A bioinformatics resource dedicated to physiological protein phosphorylation. Proteomics 4, 1551-1561 (2004).
7. N. Farriol-Mathis, J. S. Garavelli, B. Boeckmann, S. Duvaud, E. Gasteiger, A. Gateau, A. L. Veuthey, A. Bairoch, Annotation of post-translational modifications in the Swiss-Prot knowledge base. Proteomics 4, 1537-1550 (2004).
8. F. Gnad, S. Ren, J. Cox, J. V. Olsen, B. Macek, M. Oroshi, M. Mann, PHOSIDA (phosphorylation site database): Management, structural and evolutionary investigation, and prediction of phosphosites. Genome Biol. 8, R250 (2007).
9. F. Diella, C. M. Gould, C. Chica, A. Via, T. J. Gibson, Phospho.ELM: A database of phosphorylation sites - update 2008. Nucleic Acids Res. 36, D240-D244 (2008).
10. H. Li, X. Xing, G. Ding, Q. Li, C. Wang, L. Xie, R. Zeng, Y. Li, SysPTM: A systematic resource for proteomic research on post-translational modifications. Mol. Cell. Proteomics 8, 1839-1849 (2009).
11. B. Bodenmiller, D. Campbell, B. Gerrits, H. Lam, M. Jovanovic, P. Picotti, R. Schlapbach, R. Aebersold, PhosphoPep - a database of protein phosphorylation sites in model organisms. Nat. Biotechnol. 26, 1339-1340 (2008).
12. P. Durek, R. Schmidt, J. L. Heazlewood, A. Jones, D. MacLean, A. Nagel, B. Kersten, W. X. Schulze, PhosPhAt: The Arabidopsis thaliana phosphorylation site database. An update. Nucleic Acids Res. 38, D828-D834 (2010).
13. P. A. Grimsrud, D. den Os, C. D. Wenger, D. L. Swaney, D. Schwartz, M. R. Sussman, J. M. Ane, J. J. Coon, Large-scale phosphoprotein analysis in Medicago truncatula roots provides insight into in vivo kinase activity in legumes. Plant Physiol. 152, 19-28 (2010).
14. L. M. Schang, A. Bantly, M. Knockaert, F. Shaheen, L. Meijer, M. H. Malim, N. S. Gray, P. A. Schaffer, Pharmacological cyclin-dependent kinase inhibitors inhibit replication of wild-type and drug-resistant strains of herpes simplex virus and human immunodeficiency virus type 1 by targeting cellular, not viral, proteins. J. Virol. 76, 7874-7882 (2002).
15. D. Schwartz, M. F. Chou, G. M. Church, Predicting protein post-translational modifications using meta-analysis of proteome scale data sets. Mol. Cell. Proteomics 8, 365-379 (2009).
16. M. Lederman, J. T. Patton, E. R. Stout, R. C. Bates, Virally coded noncapsid protein associated with bovine parvovirus infection. J. Virol. 49, 315-318 (1984).
17. Y. Shi, G. E. Dodson, S. Shaikh, K. Rundell, R. S. Tibbetts, Ataxia-telangiectasia-mutated (ATM) is a T-antigen kinase that controls SV40 viral replication in vivo. J. Biol. Chem. 280, 40195-40200 (2005).
18. D. Schwartz, S. P. Gygi, An iterative statistical approach to the identification of protein phosphorylation motifs from large-scale data sets. Nat. Biotechnol. 23, 1391-1398 (2005).
19. P. W. Yang, S. S. Chang, C. H. Tsai, Y. H. Chao, M. R. Chen, Effect of phosphorylation on the transactivation activity of Epstein-Barr virus BMRF1, a major target of the viral BGLF4 kinase. J. Gen. Virol. 89, 884-895 (2008).
20. M. Baumann, H. Mischak, S. Dammeier, W. Kolch, O. Gires, D. Pich, R. Zeidler, H. J. Delecluse, W. Hammerschmidt, Activation of the Epstein-Barr virus transcription factor BZLF1 by 12-O-tetradecanoylphorbol-13-acetate-induced phosphorylation. J. Virol. 72, 8105-8114 (1998).
21. A. S. El-Guindy, G. Miller, Phosphorylation of Epstein-Barr virus ZEBRA protein at its casein kinase 2 sites mediates its ability to repress activation of a viral lytic cycle late gene by Rta. J. Virol. 78, 7634-7644 (2004).
22. A. S. El-Guindy, S. Y. Paek, J. Countryman, G. Miller, Identification of constitutive phosphorylation sites on the Epstein-Barr virus ZEBRA protein. J. Biol. Chem. 281, 3085-3095 (2006).
23. R. Asai, A. Kato, Y. Kawaguchi, Epstein-Barr virus protein kinase BGLF4 interacts with viral transactivator BZLF1 and regulates its transactivation activity. J. Gen. Virol. 90, 1575-1581 (2009).
24. K. Shire, P. Kapoor, K. Jiang, M. N. Hing, N. Sivachandran, T. Nguyen, L. Frappier, Regulation of the EBNA1 Epstein-Barr virus protein by serine phosphorylation and arginine methylation. J. Virol. 80, 5261-5272 (2006).
25. S. J. Duellman, K. L. Thompson, J. J. Coon, R. R. Burgess, Phosphorylation sites of Epstein-Barr virus EBNA1 regulate its function. J. Gen. Virol. 90, 2251-2259 (2009).
26. B. Kwiatkowski, S. Y. Chen, W. H. Schubach, CKII site in Epstein-Barr virus nuclear protein 2 controls binding to hSNF5/Ini1 and is important for growth transformation. J. Virol. 78, 6067-6072 (2004).
27. W. Yue, J. Shackelford, J. S. Pagano, cdc2/cyclin B1-dependent phosphorylation of EBNA2 at Ser243 regulates its function in mitosis. J. Virol. 80, 2045-2050 (2006).
28. A. Yokoyama, M. Tanaka, G. Matsuda, K. Kato, M. Kanamori, H. Kawasaki, H. Hirano, I. Kitabayashi, M. Ohki, K. Hirai, Y. Kawaguchi, Identification of major phosphorylation sites of Epstein-Barr virus nuclear antigen leader protein (EBNA-LP): Ability of EBNA-LP to induce latent membrane protein 1 cooperatively with EBNA-2 is regulated by phosphorylation. J. Virol. 75, 5119-5128 (2001).
29. R. K. Moorthy, D. A. Thorley-Lawson, Biochemical, genetic, and functional analyses of the phosphorylation sites on the Epstein-Barr virus-encoded oncogenic latent membrane protein LMP-1. J. Virol. 67, 2637-2645 (1993).
30. K. Y. Chien, Y. S. Chang, J. S. Yu, L. W. Fan, C. W. Lee, L. M. Chi, Identification of a new in vivo phosphorylation site in the cytoplasmic carboxyl terminus of EBV-LMP1 by tandem mass spectrometry. Biochem. Biophys. Res. Commun. 348, 47-55 (2006).
31. C. G. Panousis, D. T. Rowe, Epstein-Barr virus latent membrane protein 2 associates with and is a substrate for mitogen-activated protein kinase. J. Virol. 71, 4752-4760 (1997).
32. S. Fruehling, R. Longnecker, The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction. Virology 235, 241-251 (1997).
33. L. V. Matskova, C. Helmstetter, R. J. Ingham, G. Gish, C. K. Lindholm, I. Ernberg, T. Pawson, G. Winberg, The Shb signalling scaffold binds to and regulates constitutive signals from the Epstein-Barr virus LMP2A membrane protein. Oncogene 26, 4908-4917 (2007).
34. Q. Xi, R. Cuesta, R. J. Schneider, Regulation of translation by ribosome shunting through phosphotyrosine-dependent coupling of adenovirus protein 100k to viral mRNAs. J. Virol. 79, 5676-5683 (2005).
35. V. Cleghon, A. Piderit, D. E. Brough, D. F. Klessig, Phosphorylation of the adenovirus DNA-binding protein and epitope mapping of monoclonal antibodies against it. Virology 197, 564-575 (1993).
36. M. L. Tremblay, C. J.McGlade, G. E. Gerber, P. E. Branton, Identification of the phosphorylation sites in early region 1A proteins of adenovirus type 5 by amino acid sequencing of peptide fragments. J. Biol. Chem. 263, 6375-6383 (1988).
37. C. L. Smith, C. Debouck, M. Rosenberg, J. S. Culp, Phosphorylation of serine residue 89 of human adenovirus E1A proteins is responsible for their characteristic electrophoretic mobility shifts, and itsmutation affects biological function. J. Virol. 63, 1569-1577 (1989).
38. D. J. Dumont, R. C. Marcellus, S. T. Bayley, P. E. Branton, Role of phosphorylation near the amino terminus of adenovirus type 5 early region 1A proteins. J. Gen. Virol. 74, 583-595 (1993).
39. S. G. Whalen, R. C. Marcellus, D. Barbeau, P. E. Branton, Importance of the Ser-132 phosphorylation site in cell transformation and apoptosis induced by the adenovirus type 5 E1A protein. J. Virol. 70, 5373-5383 (1996).
40. S. G. Whalen, R. C. Marcellus, A. Whalen, N. G. Ahn, R. P. Ricciardi, P. E. Branton, Phosphorylation within the transactivation domain of adenovirus E1A protein by mitogen-activated protein kinase regulates expression of early region 4. J. Virol. 71, 3545-3553 (1997).
41. A. S. Turnell, R. J. Grand, C. Gorbea, X. Zhang, W.Wang, J. S. Mymryk, P. H. Gallimore, Regulation of the 26S proteasome by adenovirus E1A. EMBO J. 19, 4759-4773 (2000).
42. C. J. McGlade, M. L. Tremblay, P. E. Branton, Mapping of a phosphorylation site in the 176R (19 kDa) early region 1B protein of human adenovirus type 5. Virology 168, 119-127 (1989).
43. D. Takayesu, J. G. Teodoro, S. G. Whalen, P. E. Branton, Characterization of the 55K adenovirus type 5 E1B product and related proteins. J. Gen. Virol. 75, 789-798 (1994).
44. D. L. Lichtenstein, P. Krajcsi, D. J. Esteban, A. E. Tollefson, W. S. Wold, Adenovirus RIDβ subunit contains a tyrosine residue that is critical for RID-mediated receptor internalization and inhibition of Fas- and TRAIL-induced apoptosis. J. Virol. 76, 11329-11342 (2002).
45. M. Ramachandra, R. Nakano, P. M. Mohan, A. B. Rawitch, R. Padmanabhan, Adenovirus DNA polymerase is a phosphoprotein. J. Biol. Chem. 268, 442-448 (1993).
46. A. Kato, J. Arii, I. Shiratori, H. Akashi, H. Arase, Y. Kawaguchi, Herpes simplex virus 1 protein kinase Us3 phosphorylates viral envelope glycoprotein B and regulates its expression on the cell surface. J. Virol. 83, 250-261 (2009).
47. D. J. Davido, W. F. von Zagorski, W. S. Lane, P. A. Schaffer, Phosphorylation site mutations affect herpes simplex virus type 1 ICP0 function. J. Virol. 79, 1232-1243 (2005).
48. K. Xia, N. A. DeLuca, D. M. Knipe, Analysis of phosphorylation sites of herpes simplex virus type 1 ICP4. J. Virol. 70, 1061-1071 (1996).
49. C. R. Brandt, A. W. Kolb, Tyrosine 116 of the herpes simplex virus type 1 IEα22 protein is an ocular virulence determinant and potential phosphorylation site. Invest. Ophthalmol. Vis. Sci. 44, 4601-4607 (2003).
50. Y. Zhi, R. M. Sandri-Goldin, Analysis of the phosphorylation sites of herpes simplex virus type 1 regulatory protein ICP27. J. Virol. 73, 3246-3257 (1999).
51. D. O'Reilly, O. Hanscombe, P. O'Hare, A single serine residue at position 375 of VP16 is critical for complex assembly with Oct-1 and HCF and is a target of phosphorylation by casein kinase II. EMBO J. 16, 2420-2430 (1997).
52. S. Ottosen, F. J. Herrera, J. R. Doroghazi, A. Hull, S. Mittal, W. S. Lane, S. J. Triezenberg, Phosphorylation of the VP16 transcriptional activator protein during herpes simplex virus infection andmutational analysis of putative phosphorylation sites. Virology 345, 468-481 (2006).
53. A. Kato, M. Yamamoto, T. Ohno, H. Kodaira, Y. Nishiyama, Y. Kawaguchi, Identification of proteins phosphorylated directly by the Us3 protein kinase encoded by herpes simplex virus 1. J. Virol. 79, 9325-9331 (2005).
54. J. S. Loomis, J. B. Bowzard, R. J. Courtney, J. W. Wills, Intracellular trafficking of the UL11 tegument protein of herpes simplex virus type 1. J. Virol. 75, 12209-12219 (2001).
55. A. Kato, M. Tanaka, M. Yamamoto, R. Asai, T. Sata, Y. Nishiyama, Y. Kawaguchi, Identification of a physiological phosphorylation site of the herpes simplex virus 1-encoded protein kinase Us3 which regulates its optimal catalytic activity in vitro and influences its function in infected cells. J. Virol. 82, 6172-6189 (2008).
56. C. Cartier, P. Sivard, C. Tranchat, D. Decimo, C. Desgranges, V. Boyer, Identification of three major phosphorylation sites within HIV-1 capsid. Role of phosphorylation during the early steps of infection. J. Biol. Chem. 274, 19434-19440 (1999).
57. G. Yu, F. S. Shen, S. Sturch, A. Aquino, R. I. Glazer, R. L. Felsted, Regulation of HIV-1 gag protein subcellular targeting by protein kinase C. J. Biol. Chem. 270, 4792-4796 (1995).
58. P. Gallay, S. Swingler, C. Aiken, D. Trono, HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viralmatrix protein is a key regulator. Cell 80, 379-388 (1995).
59. B. Guy, M. P. Kieny, Y. Riviere, C. LePeuch, K. Dott, M. Girard, L. Montagnier, J. P. Lecocq, HIV F/3′ orf encodes a phosphorylated GTP-binding protein resembling an oncogene product. Nature 330, 266-269 (1987).
60. P. L. Li, T. Wang, K. A. Buckley, A. L. Chenine, S. Popov, R. M. Ruprecht, Phosphorylation of HIV Nef by cAMP-dependent protein kinase. Virology 331, 367-374 (2005).
61. M. H. Malim, S. Bohnlein, J. Hauber, B. R. Cullen, Functional dissection of the HIV-1 Rev trans-activator - derivation of a trans-dominant repressor of Rev function. Cell 58, 205-214 (1989).
62. F. Meggio, D. M. D'Agostino, V. Ciminale, L. Chieco-Bianchi, L. A. Pinna, Phosphorylation of HIV-1 Rev protein: Implication of protein kinase CK2 and pro-directed kinases. Biochem. Biophys. Res. Commun. 226, 547-554 (1996).
63. S. R. Brand, R. Kobayashi, M. B. Mathews, The Tat protein of human immunodeficiency virus type 1 is a substrate and inhibitor of the interferon-induced, virally activated protein kinase, PKR. J. Biol. Chem. 272, 8388-8395 (1997).
64. X. Yang, J. Goncalves, D. Gabuzda, Phosphorylation of Vif and its role in HIV-1 replication. J. Biol. Chem. 271, 10121-10129 (1996).
65. X. Yang, D. Gabuzda, Mitogen-activated protein kinase phosphorylates and regulates the HIV-1 Vif protein. J. Biol. Chem. 273, 29879-29887 (1998).
66. Y. Zhou, L. Ratner, Phosphorylation of human immunodeficiency virus type 1 Vpr regulates cell cycle arrest. J. Virol. 74, 6520-6527 (2000).
67. U. Schubert, T. Schneider, P. Henklein, K. Hoffmann, E. Berthold, H. Hauser, G. Pauli, T. Porstmann, Human-immunodeficiency-virus-type-1-encoded Vpu protein is phosphorylated by casein kinase II. Eur. J. Biochem. 204, 875-883 (1992).
68. E. Estrabaud, E. Le Rouzic, S. Lopez-Vergès, M. Morel, N. Belaïdouni, R. Benarous, C. Transy, C. Berlioz-Torrent, F. Margottin-Goguet, Regulated degradation of the HIV-1 Vpu protein through a βTrCP-independent pathway limits the release of viral particles. PLoS Pathog. 3, e104 (2007).
69. 900) is required for localization of gB to the trans-Golgi network and efficient virus replication. J. Virol. 78, 285-293 (2004).
70. J. Reinhardt, G. B. Smith, C. T. Himmelheber, J. Azizkhan-Clifford, E. S. Mocarski, The carboxyl-terminal region of human cytomegalovirus IE1491aa contains an acidic domain that plays a regulatory role and a chromatin-tethering domain that is dispensable during viral replication. J. Virol. 79, 225-233 (2005).
71. N. Y. Harel, J. C. Alwine, Phosphorylation of the human cytomegalovirus 86-kilodalton immediate-early protein IE2. J. Virol. 72, 5481-5492 (1998).
72. H. Pande, T. D. Lee, M. A. Churchill, J. A. Zaia, Structural analysis of a 64-kDa major structural protein of human cytomegalovirus (Towne): Identification of a phosphorylation site and comparison to pp65 of HCMV (AD169). Virology 178, 6-14 (1990).
73. M. C. Baek, P. M. Krosky, D. M. Coen, Relationship between autophosphorylation and phosphorylation of exogenous substrates by the human cytomegalovirus UL97 protein kinase. J. Virol. 76, 11943-11952 (2002).
74. Acknowledgments: We thank M. Chou for his continued work in developing the scan-x algorithm and software and the Harvard Medical School Research Information Technology Group for hosting the virPTM Web site. Funding: This work was supported in part by NIH grant GM068763 and the U.S. Department of Energy Genome Sciences Program. Author contributions: D.S. curated the database, designed and performed analyses, and wrote the manuscript; G.M.C. provided conceptual advice and edited the manuscript. Competing interests: Technology transfer and commercial scientific advisory roles for G.M.C. can be found at: http://arep.med.harvard.edu/gmc/tech.html